Elsevier

Gynecologic Oncology

Volume 86, Issue 2, August 2002, Pages 134-137
Gynecologic Oncology

Regular Article
Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Ovarian Cancer

https://doi.org/10.1006/gyno.2002.6749Get rights and content

Abstract

Objective. The free radical nitric oxide is known to be critically involved in ovarian carcinogenesis by inducing apoptosis and by mediating various cytostatic and cytotoxic effects, but also by promoting growth, invasion, and metastasis.

Methods. We investigated two polymorphisms (exon 7 Glu298Asp and a 27-bp repeat in intron 4) of the gene encoding endothelial nitric oxide synthase (Nos3) in 130 patients with ovarian cancer, 26 patients with borderline ovarian cancer, and 133 healthy age-matched Caucasian women using PCR and pyrosequencing, respectively.

Results. Genotypes and allelic frequencies did not differ between patients with ovarian cancer and controls. Within the ovarian cancer group, however, the presence of at least one mutant allele of intron 4 was associated with advanced tumor stage and positive lymph node involvement, but not with tumor grading. The presence of the mutant allele of exon 7 was not associated with the investigated clinicopathological parameters. No correlation with patients' overall and disease-free survival was ascertained.

Conclusions. We are the first to report on Nos3 polymorphisms in ovarian cancer. Allelic variation within intron 4 of Nos3 is associated with an advanced tumor stage and positive lymph node involvement in ovarian cancer.

References (26)

  • R Farias-Eisner et al.

    Nitric oxide is an important mediator for tumoricidal activity in vivo

    Proc Natl Acad Sci USA

    (1994)
  • Y Nakamura et al.

    Changes in nitric oxide synthase activity in the ovary of gonadotropin treated rats: the role of nitric oxide during ovulation

    Endocr J

    (1999)
  • Cited by (0)

    View full text